AbbVie , a research and development based global biopharmaceutical company in cooperation with Neurocrine Biosciences, Inc.announced that the U.S. FDA...
Read moreAllergan plc presented new analyses of VENUS II, the second of two pivotal Phase 3 clinical trials evaluating the efficacy...
Read moreIn this role Nicholas will lead Johnson Matthey's (JM) custom development and manufacturing offering to pharmaceutical and biotechnology customers who...
Read moreAlopexx Vaccine LLC announced that it has completed a Phase 1 clinical trial with AV0328, a vaccine targeting the broadly...
Read moreSun Pharmaceutical Industries Ltd. announced that one of its wholly owned subsidiaries has received final approval from US FDA for...
Read moreRoche announced that new OCREVUS® data are being presented at the 7th Joint European Committee for Treatment and Research in...
Read more
Impax Laboratories, Inc., a specialty pharmaceutical company, announced it has received final U.S. FDA approval on its ANDA for a...
Read more
GlaxoSmithKline has won U.S. approval for a new and improved shingles vaccine, the second of three key products for which...
Read more
We are pleased to announce the appointment of Nicholas Shackley to the role of Global Vice President Innovator Products and...
Read moreAstellas Pharma Inc. announced that the U.S. FDA has granted Fast Track designation for the development of gilteritinib for adult...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
